scholarly journals A developmental framework of binge-eating disorder based on pediatric loss of control eating.

2020 ◽  
Vol 75 (2) ◽  
pp. 189-203 ◽  
Author(s):  
Marian Tanofsky-Kraff ◽  
Natasha A. Schvey ◽  
Carlos M. Grilo
2012 ◽  
Vol 46 (3) ◽  
pp. 233-238 ◽  
Author(s):  
Garrett A. Pollert ◽  
Scott G. Engel ◽  
Deanna N. Schreiber‐Gregory ◽  
Ross D. Crosby ◽  
Li Cao ◽  
...  

2016 ◽  
Vol 246 ◽  
pp. 548-553 ◽  
Author(s):  
Christina A. Roberto ◽  
Katharine Galbraith ◽  
Janet A. Lydecker ◽  
Valentina Ivezaj ◽  
Rachel D. Barnes ◽  
...  

2015 ◽  
Vol 230 (2) ◽  
pp. 242-248 ◽  
Author(s):  
Alexandra E. Dingemans ◽  
Hiske Visser ◽  
Linda Paul ◽  
Eric F. van Furth

Obesity ◽  
2012 ◽  
Vol 20 (6) ◽  
pp. 1206-1211 ◽  
Author(s):  
Andrea B. Goldschmidt ◽  
Scott G. Engel ◽  
Stephen A. Wonderlich ◽  
Ross D. Crosby ◽  
Carol B. Peterson ◽  
...  

2021 ◽  
Vol 9 (1) ◽  
Author(s):  
Simone Munsch ◽  
Felicitas Forrer ◽  
Adrian Naas ◽  
Verena Mueller ◽  
Marius Rubo ◽  
...  

Abstract Background Binge Eating Disorder (BED) represents a common eating disorder associated with marked health impairments. A subclinical variant, loss of control eating (LOC) is prevalent in youth. LOC is associated with similar mental distress as full-blown BED, increases the risk to develop a BED and promotes continuous weight gain. The etiology of LOC is not yet fully understood and specialized treatment for youth is scarce. Methods The i-BEAT study includes a cross-sectional and longitudinal online questionnaire study (N = 600), an App based daily-life approach and a laboratory virtual reality study in N = 60 youths (14–24 years) with and without LOC as well as a controlled randomized online treatment trial to investigate the feasibility, acceptance and efficacy of a CBT and an interpersonal emotion regulation module for youth (N = 120). The primary outcomes include self-reported as well as measured (heart rate variability, gaze behavior, reaction times in stop signal task) associations between emotion regulation problems (such as dealing with RS), psychological impairment and binge eating in a healthy control group and youth with LOC. Secondary outcomes encompass general eating disorder pathology, social anxiety, body mass index, hyperscanning behavior and therapists’ rating of patients’ condition pre and post treatment. Epigenetic correlates of RS are assessed in healthy controls and youth with LOC and explored before and after treatment. Discussion The expected findings will specify the role of interpersonal emotion regulation problems such as coping with the experience of social exclusion and rejection sensitivity (RS) in LOC and clarify, whether including a training to cope with RS adds to the efficacy of a cognitive behavioral treatment (CBT). Trial registration: German Clinical Trial Register: DRKS00023706. Registered 27 November 2020, https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00023706


2020 ◽  
Vol 8 (1) ◽  
Author(s):  
Laura A. Berner ◽  
Robyn Sysko ◽  
Tahilia J. Rebello ◽  
Christina A. Roberto ◽  
Kathleen M. Pike

Abstract Background Although data suggest that the sense of “loss of control” (LOC) is the most salient aspect of binge eating, the definition of LOC varies widely across eating disorder assessments. The WHO ICD-11 diagnostic guidelines for binge eating do not require an objectively large amount of food, which makes accurate LOC diagnosis even more critical. However, it can be especially challenging to assess LOC in the context of elevated weight status and in the absence of compensatory behaviors. This ICD-11 field sub-study examined how descriptions of subjective experience during distressing eating episodes, in combination with different eating episode sizes, influence diagnoses of binge-eating disorder (BED). Method Mental health professionals with eating disorder expertise from WHO’s Global Clinical Practice Network (N = 192) participated in English, Japanese, and Spanish. Participants were asked to select the correct diagnosis for two randomly assigned case vignettes and to rate the clinical importance and ease of use of each BED diagnostic guideline. Results The presence of LOC interacted with episode size to predict whether a correct diagnostic conclusion was reached. If the amount consumed during a typical distressing eating episode was only subjectively large compared to objectively large, clinicians were 23.1 times more likely to miss BED than to correctly diagnose it, and they were 9.7 times more likely to incorrectly diagnose something else than to correctly diagnose BED. In addition, clinicians were 10.8 times more likely to make a false positive diagnosis of BED when no LOC was described if the episode was objectively large. Descriptions of LOC that were reliably associated with correct diagnoses across episodes sizes included two that are similar to those already included in proposed ICD-11 guidelines and a third that is not. This third description of LOC focuses on giving up attempts to control eating because perceived overeating feels inevitable. Conclusions Results highlight the importance of detailed clarification of the LOC construct in future guidelines. Explicitly distinguishing LOC from distressing and mindless overeating could help promote consistent and accurate diagnosis of BED versus another or no eating disorder.


2021 ◽  
Vol 12 ◽  
Author(s):  
Kristi R. Griffiths ◽  
Leonor Aparício ◽  
Taylor A. Braund ◽  
Jenny Yang ◽  
Grace Harvie ◽  
...  

High trait impulsivity is thought to contribute to the sense of loss of control over eating and impulses to binge eat experienced by those with binge eating disorder (BED). Lisdexamfetamine dimesylate (LDX), a drug approved for treatment of moderate to severe BED, has been shown to decrease impulsive features of BED. However, the relationship between LDX-related reductions of binge eating (BE) episodes and impulsivity has not yet been explored. Forty-one adults aged 18–40years with moderate to severe BED completed questionnaires and tasks assessing impulsivity at baseline and after 8weeks of 50–70mg of LDX. Twenty age-matched healthy controls were also assessed at two timepoints for normative comparison. Data were analysed using linear mixed models. BED participants exhibited increased self-reported motor, non-planning, cognitive and food-related impulsivity relative to controls but no differences in objective task-based measures of impulsivity. Food-related and non-planning impulsivity was significantly reduced by LDX, but not to normative levels. Individuals with higher baseline levels of motor and non-planning impulsivity, and loss of control over eating scores experienced the greatest reduction in BE frequency after 8weeks of LDX. Further, there were significant associations between the degree to which subjective loss of control over eating, non-planning impulsivity and BE frequency reduced after 8weeks of LDX. These data suggest that specific subjective measures of impulsivity may be able to predict who will have the greatest benefit from LDX treatment and that reductions in BE frequency may be moderated by concurrent reductions in non-planning impulsivity.


Sign in / Sign up

Export Citation Format

Share Document